Cytokinetics reported $74.64M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Acorda Therapeutics ACOR:US $ 54.46M 6.99M
Amgen AMGN:US $ 4.33B 1.37B
Arca Biopharma ABIO:US $ 4.1M 2.11M
Bayer BAYN:GR 9.25B 3.88B
Biogen BIIB:US $ 1984.9M 304.4M
Brainstorm Cell Therapeutics BCLI:US $ 5.28M 844K
Bristol Myers Squibb BMY:US $ 9.63B 360M
Capricor Therapeutics CAPR:US $ 4.31M 654.54K
Cytokinetics CYTK:US $ 74.64M 17M
Eisai 4523:JP Y 157959M 14472M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Exelixis EXEL:US $ 276.8M 14.63M
Genocea Biosciences GNCA:US $ 13.36M 1.19M
Geron GERN:US $ 25.78M 3.21M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Intra Cellular Therapies ITCI:US $ 99.53M 10.34M
Ligand Pharmaceuticals LGND:US $ 49.23M 7.99M
Merk MRK:US $ 8328M 1460M
Novartis NOVN:VX 10.13B 319M
Pfizer PFE:US $ 16447M 3384M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M